Intervention: Fulvestrant or an Aromatase Inhibitor (Physician Choice)
Found 4 matching trials
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
PHASE2
This Phase II, randomized, open-label, multicenter study will evaluate the ...
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment
N/A
This is a non-interventional observational study conducted in Germany to ev...